Antibodies to serine proteases in the antiphospholipid syndrome

Current Rheumatology Reports

Volumn 12, Issue 1, 2010, Pages 45-52

  Chen, Pojen P ^a   Giles, Ian ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Activated protein C; Hemostasis; Plasmin; Thrombin; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 9A; ENZYME ANTIBODY; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; PLASMIN; SERINE PROTEINASE; SERINE PROTEINASE ANTIBODY; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; ENZYME CONFORMATION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; LEUKOCYTE ADHERENCE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBINS; EPITOPES; FIBRINOLYSIS; HUMANS; IMMUNOGLOBULIN G; SERINE PROTEASES; THROMBIN; THROMBOSIS;

EID: 77249100694     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0072-7     Document Type: Review

References (50)

1. S Miyakis MD Lockshin T Atsumi, et al. 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295 306 10.1111/j.1538-7836. 2006.01753.x 1:CAS:528:DC%2BD28XisVSjuro%3D 16420554
2. ML Bertolaccini MA Khamashta GR Hughes 2005 Diagnosis of antiphospholipid syndrome Nat Clin Pract Rheumatol 1 40 46 10.1038/ncprheum0017 1:CAS:528:DC%2BD28Xis1artbc%3D 16932626
3. SS Pierangeli PP Chen E Raschi, et al. 2008 Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms Semin Thromb Hemost 34 236 250 10.1055/s-0028-1082267 1:CAS:528:DC%2BD1MXnvF2gur8%3D 18720303
4. MD Lockshin RH Derksen 2008 New developments in lupus-associated antiphospholipid syndrome Lupus 17 443 446 10.1177/0961203308090032 1:STN:280:DC%2BD1czislajsg%3D%3D 18490424 (Pubitemid 351798724)
5. SS Pierangeli M Stewart LK Silva EN Harris 1998 An antiphospholipid wet workshop: 7th International Symposium on Antiphospholipid Antibodies J Rheumatol 25 156 160 1:STN:280:DyaK1c7hslChtw%3D%3D 9458221
6. JT Brandt LK Barna DA Triplett 1995 Laboratory identification of lupus anticoagulants: results of the Second International Workshop for identification of lupus anticoagulants. On behalf of the subcommittee on lupus anticoagulants antiphospholipid antibodies of the ISTH Thromb Haemost 74 1597 1603 1:CAS:528:DyaK28Xjtlynuw%3D%3D 8772243
7. RA Fleck SI Rapaport LV Rao 1988 Anti-prothrombin antibodies and the lupus anticoagulant Blood 72 512 519 1:STN:280:DyaL1c3psVejsA%3D%3D 2456797
8. HP McNeil RJ Simpson CN Chesterman SA Krilis 1990 Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) Proc Natl Acad Sci USA 87 4120 4124 10.1073/pnas.87.11.4120 1:CAS:528:DyaK3cXktlymtbo%3D 2349221 (Pubitemid 20217993)
9. JD Oosting RH Derksen IW Bobbink, et al. 1993 Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 81 2618 2625 1:CAS:528:DyaK3sXkslSjtrs%3D 8166780
10. P Permpikul LV Rao SI Rapaport 1994 Functional and binding studies of the roles of prothrombin and b2-glycoprotein I in the expression of lupus anticoagulant activity Blood 83 2878 2892 1:CAS:528:DyaK2cXltVKgt78%3D 8180383
11. DW Branch DJ Dudley MD Mitchell, et al. 1990 Immunoglobulin G fractions from patients with antiphospholipid antibodies caused fetal death in Balb/c mice: a model for autoimmune fetal loss Am J Obstet Gynecol 163 210 216 1:STN:280:DyaK3czivVajsg%3D%3D 2197866
12. SS Pierangeli M Colden-Stanfield XW Liu, et al. 1999 Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo Circulation 99 1997 2002 1:CAS:528:DyaK1MXivFSrsbo%3D 10209004 (Pubitemid 29183897)
13. R Cariou G Tobelem S Bellucci, et al. 1988 Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells-inhibition of thrombomodulin-dependent protein C activation Thromb Haemost 60 54 58 1:STN:280:DyaL1M%2FksVOjtA%3D%3D 2847352
14. E Marciniak EH Romond 1989 Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant Blood 74 2426 2432 1:STN:280:DyaK3c%2FivVOrtw%3D%3D 2508795
15. M Borrell N Sala C de Castellarnau, et al. 1992 Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells Thromb Haemost 68 268 272 1:STN:280:DyaK3s%2FmvFSkug%3D%3D 1440490
16. G Escolar J Font JC Reverter, et al. 1992 Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation Arterioscler Thromb 12 196 200 1:STN:280:DyaK387otF2isg%3D%3D 1543693
17. M Vega-Ostertag EN Harris SS Pierangeli 2004 Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin Arthritis Rheum 50 2911 2919 10.1002/art.20434 1:CAS:528:DC%2BD2cXoslGgsb4%3D 15457460 (Pubitemid 39209530)
18. A Kornberg M Blank S Kaufman Y Shoenfeld 1994 Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies J Immunol 153 1328 1332 1:CAS:528:DyaK2cXlsFGntbc%3D 8027560
19. R Simantov JM LaSala SK Lo, et al. 1995 Activation of cultured vascular endothelial cells by antiphospholipid antibodies J Clin Invest 96 2211 2219 10.1172/JCI118276 1:CAS:528:DyaK28XltF2jtA%3D%3D 7593607
20. O Amengual T Atsumi MA Khamashta GR Hughes 1998 The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome Thromb Haemost 79 276 281 1:CAS:528:DyaK1cXhtVeju7Y%3D 9493575
21. M Vega-Ostertag K Casper R Swerlick, et al. 2005 Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies Arthritis Rheum 52 1545 1554 10.1002/art.21009 1:CAS:528: DC%2BD2MXkvFCisrg%3D 15880836 (Pubitemid 40663946)
22. VM Holers G Girardi L Mo, et al. 2002 Complement c3 activation is required for antiphospholipid antibody-induced fetal loss J Exp Med 195 211 220 10.1084/jem.200116116 1:CAS:528:DC%2BD38XosFCnsA%3D%3D 11805148 (Pubitemid 34461265)
23. SS Pierangeli G Girardi M Vega-Ostertag, et al. 2005 Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia Arthritis Rheum 52 2120 2124 10.1002/art.21157 1:CAS:528:DC%2BD2MXnsl2gt7w%3D 15986360 (Pubitemid 40994335)
24. B Dahlback 2000 Blood coagulation Lancet 355 1627 1632 10.1016/S0140-6736(00)02225-X 1:CAS:528:DC%2BD3cXjs1Glu7s%3D 10821379
25. ID Walker 1997 Congenital thrombophilia Baillieres Clin Obstet Gynaecol 11 431 445 10.1016/S0950-3552(97)80020-X 1:STN:280:DyaK1c7ltVSnsA%3D%3D 9488784 (Pubitemid 27470550)
26. RL Bick H Kaplan 1998 Syndromes of thrombosis and hypercoagulability: congenital and acquired causes of thrombosis Med Clin North Am 82 409 458 10.1016/S0025-7125(05)70004-3 1:STN:280:DyaK1czhtVOnsw%3D%3D 9646773 (Pubitemid 28244018)
27. LV Rao AD Hoang SI Rapaport 1996 Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid Blood 88 4173 4182 1:CAS:528:DyaK28XntlKgur0%3D 8943852
28. Y Zhao R Rumold M Zhu, et al. 1999 An IgG anti-prothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times Arthritis Rheum 42 2132 2138 10.1002/1529-0131(199910)42: 10<2132::AID-ANR13>3.0.CO;2-B 1:CAS:528:DyaK1MXmvV2ks7o%3D 10524684 (Pubitemid 30263596)
29. M Vega-Ostertag X Liu H Kwan-Ki, et al. 2006 A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells Br J Haematol 135 214 219 10.1111/j.1365-2141.2006.06283.x 1:CAS:528:DC%2BD28Xht1Wntb%2FK 16965389 (Pubitemid 44401619)
30. JD Pearson 1999 Endothelial Cell function and thrombosis Baillieres Best Pract Res Clin Haematol 12 329 341 1:STN:280:DC%2BD3czhtFSqsg%3D%3D 10856973
31. KK Hwang JM Grossman S Visvanathan, et al. 2001 Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin J Immunol 167 7192 7198 1:CAS:528:DC%2BD3MXptFGhsrg%3D 11739542
32. SS Pierangeli X Liu R Espinola, et al. 2000 Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models Thromb Haemost 84 388 395 1:CAS:528:DC%2BD3MXjtVOksLw%3D 11019960
33. KK Hwang CD Yang W Yan, et al. 2003 A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C Arthritis Rheum 48 1622 1630 10.1002/art.10983 1:CAS:528:DC%2BD3sXltlSgu74%3D 12794830 (Pubitemid 36682370)
34. CD Yang KK Hwang W Yan, et al. 2004 Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin J Immunol 172 5765 5773 1:CAS:528:DC%2BD2cXjt1CkurY%3D 15100323
35. K Kolev J Gombas B Varadi, et al. 2002 Immunoglobulin g from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin Thromb Haemost 87 502 508 1:CAS:528:DC%2BD38XislGjsrY%3D 11916083
36. A Tincani L Spatola E Prati, et al. 1996 The anti-b2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native b2-glycoprotein I and preserved during species' evolution J Immunol 157 5732 5738 1:CAS:528:DyaK28XnsFCnu7Y%3D 8955227
37. M Zhu T Olee DT Le, et al. 1999 Characterization of IgG monoclonal anti-cardiolipin/antib2GP1 antibodies from two patients with the anti-phospholipid syndrome reveals three species of antibodies Br J Haematol 105 102 109 10.1111/j.1365-2141.1999.01292.x 1:STN:280:DyaK1M3ltVGisw%3D%3D 10233371 (Pubitemid 29197150)
38. CS Lu AA Horizon KK Hwang, et al. 2005 Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome Arthritis Rheum 52 4018 4027 10.1002/art.21485 1:CAS:528:DC%2BD28XjvF2gsw%3D%3D 16320350 (Pubitemid 41798242)
39. M Cugno M Cabibbe M Galli, et al. 2004 Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients Blood 103 2121 2126 10.1182/blood-2003-07-2422 1:CAS:528: DC%2BD2cXitlequro%3D 14630788 (Pubitemid 38326228)
40. WS Lin PC Chen CD Yang, et al. 2007 Some antiphospholipid antibodies recognize conformational epitopes shared by beta(2)-glycoprotein I and the homologous catalytic domains of several serine proteases Arthritis Rheum 56 1638 1647 10.1002/art.22522 1:CAS:528:DC%2BD2sXmsFartLY%3D 17469158 This paper showed that both patient-derived IgG monoclonal anti-β2GPI antibodies bind to three serine proteases in hemostasis and that a patient-derived IgG mAb against protein C (P1) reacted with β2GPI. Moreover, P1 binding to β2GPI and thrombin was crossinhibited by both antigens, indicating that the P1 aPL recognizes shared epitope(s) on β2GPI and thrombin, which represents the homologous enzymatic domains of several targeted serine protease (Pubitemid 46764093)
41. XX Chen YY Gu SJ Li, et al. 2007 Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice J Immunol 178 5351 5356 1:CAS:528:DC%2BD2sXjslWjtb0%3D 17404320 This paper showed that plasmin immunization in mice induced pathogenic aPL
42. T Exner KA Rickard H Kronenberg 1978 A sensitive test demonstrating lupus anticoagulant and its behavioural patterns Br J Haematol 40 143 151 10.1111/j.1365-2141.1978.tb03648.x 1:STN:280:DyaE1M%2FktF2qsQ%3D%3D 568479
43. M Petri 2000 Epidemiology of the antiphospholipid antibody syndrome J Autoimmun 15 145 151 10.1006/jaut.2000.0409 1:STN:280:DC%2BD3M7nvVWjsg%3D%3D 10968901 (Pubitemid 30707584)
44. I Giles A Rahman 2009 How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive Best Pract Res Clin Rheumatol 23 525 537 10.1016/j.berh.2009.01.009 19591782
45. I Giles N Lambrianides N Pattni, et al. 2006 Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens J Immunol 177 1729 1736 1:CAS:528:DC%2BD28XmvFCmu7s%3D 16849482
46. I Giles C Pericleous X Liu, et al. 2009 Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actions J Immunol 182 4836 4843 10.4049/jimmunol.0804241 1:CAS:528:DC%2BD1MXjvFOjurY%3D 19342662 This paper shows that the reactivity of a panel of closely related monoclonal aPL with thrombin, most closely predicts their ability to promote thrombosis and activate endothelial cells in a murine model of thrombosis and microcirculation
47. RM Bertina 2003 Elevated clotting factor levels and venous thrombosis Pathophysiol Haemost Thromb 33 395 400 10.1159/000083835 15692250 (Pubitemid 40278714)
48. K Kottke-Marchant A Duncan 2002 Antithrombin deficiency: issues in laboratory diagnosis Arch Pathol Lab Med 126 1326 1336 1:CAS:528: DC%2BD3sXhtFGgtr4%3D 12421140
49. B Furie DH Bing RJ Feldmann, et al. 1982 Computer-generated models of blood coagulation factor Xa, factor IXa, and thrombin based upon structural homology with other serine proteases J Biol Chem 257 3875 3882 1:CAS:528:DyaL38XhslKqtrk%3D 7037788
50. YH Yang D Chien M Wu, et al. 2009 Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin J Immunol 182 1674 1680 1:CAS:528:DC%2BD1MXnsVCjtA%3D%3D 19155517 This paper demonstrated that some aPL bound to FIXa and hindered inactivation of FIXa by antithrombin and that such FIXa-reactive aPL occurred in 11 of 38 (28.9%) patients with APS tested